Bactiguard appoints new CEO
STOCKHOLM, September 7, 2021 / PRNewswire / – “I am delighted to welcome Anders Göransson to lead Bactiguard into the future. I am confident that Anders, with his strong international experience in pharmaceuticals and healthcare, combined with the experience of McKinsey, will propel Bactiguard to new heights. healthcare has not sufficiently focused on the problems of infections and resistant bacteria, recent years have shown that companies like Bactiguard are a prerequisite for us to be able to together create a better world in which to live “, said Thomas de Koch, President of the council.
“At the same time, I would like to thank our outgoing CEO Cecilia Edström for his major contribution to the success of Bactiguard. Cecilia told the board in February that she wanted to step down as CEO after seven intensive years in the management team, but at the same time offered to continue working until she took office. of a new CEO, which she did with great commitment. The Board of Directors is also pleased that she continues as Senior Advisor and Board Member ”, Thomas de Koch keep on going.
It is with pride and energy that I look forward to assuming the role of CEO of Bactiguard. Using Bactiguard’s technology and product portfolio, we can reduce hospital-acquired infections and reduce healthcare needs around the world. More and more large medical technology companies are starting to open their eyes to our unique technology, most recently Zimmer Biomet with its ZNN Bactiguard traumatic implant, ”says Anders Göransson.
“This is just the start, all devices intended to stay in the body for more than two days should have Bactiguard infection prevention technology. It is my responsibility and that of our employees to disseminate it as widely. as possible to save lives, reduce antibiotic use and save money for healthcare providers around the world. With Bactiguard’s own products and with Bactiguard-coated products from our licensees , we are just beginning this journey, ”concludes Anders Göransson.
Anders Göransson, 50, started his career as an accountant at Ernst & Young, then worked as a consultant at McKinsey. From McKinsey, Anders moved to Amgen, where he led Swedish operations and then moved to Amgen’s European headquarters in Switzerland. Anders has held leadership positions in a number of functions, such as sales and marketing, business integration and most recently responsibility for Amgen Innovation Europe. Anders holds a BA in Commerce and Economics from Uppsala University and an MBA from Suffolk University, United States.
This information is information that Bactiguard Holding AB (publ) is obliged to make public in accordance with the EU Market Abuse Regulation. The information has been submitted for publication, through the contact person indicated below 2021-09-07, at 23.59.
For more information, please contact:
Thomas de Koch, President, by Birgitta Wrestling at +46 70 955 66 52
This information was brought to you by Cision http://news.cision.com
The following files are available for download:
SOURCE Bactiguard Holding AB (published)